| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/27/2003 | WO2003016302A1 Diamine derivatives |
| 02/27/2003 | WO2003016277A1 Cyclohept`b!indole derivatives as spla2 inhibitors |
| 02/27/2003 | WO2003016276A2 3-substituted oxindole beta-3 agonists |
| 02/27/2003 | WO2003016259A2 Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances |
| 02/27/2003 | WO2003016246A1 Fluorous nucleophilic substitution of alcohols and reagents for use therein |
| 02/27/2003 | WO2003015917A1 Amine elimination process for making single-site catalysts |
| 02/27/2003 | WO2003015769A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 02/27/2003 | WO2003015517A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/27/2003 | WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/27/2003 | WO2002085301A3 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 02/27/2003 | WO2002051813A3 PROCESS FOR THE PREPARATION OF α-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES |
| 02/27/2003 | WO2001098267A8 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 02/27/2003 | US20030040639 Reacting polymer bound chemical intermediate compound with complex to produce complex compound; reacting with nucleophile(s); benzene derivative is decomplexed, optionally derivatised, cleaved from the support |
| 02/27/2003 | US20030040538 Novel substituted tricyclic compounds |
| 02/27/2003 | US20030040518 For therapy of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons degeneration of lesioned and damaged neurons |
| 02/27/2003 | US20030040434 Color developers; recording images |
| 02/27/2003 | CA2457727A1 Amine elimination process for making single-site catalysts |
| 02/27/2003 | CA2457037A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/27/2003 | CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/26/2003 | EP1285651A1 Melanin concentrating hormone antagonists |
| 02/26/2003 | EP1284966A2 Process for the synthesis of amine ethers from secondary amino oxides |
| 02/26/2003 | EP1284965A1 Method for producing indols |
| 02/26/2003 | EP1284964A1 Process for the preparation of indole derivatives and intermediates of the process |
| 02/26/2003 | EP1284963A1 Novel calcium receptor active molecules and method for preparing same |
| 02/26/2003 | EP1284947A1 Method for formulating organic compounds |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/26/2003 | EP1284728A1 Pharmaceuticals for treating obesity |
| 02/26/2003 | EP1150976B1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 02/26/2003 | EP1141409A4 A system and methods for nucleic acid sequencing of single molecules by polymerase synthesis |
| 02/26/2003 | EP1003903B1 Process for preparing enantiomerically enriched n-derivatised lactams |
| 02/26/2003 | EP0674621B1 Enantiomers of carbazole derivatives as 5-ht1-like agonists |
| 02/26/2003 | CN1399635A Piperazing derivatives as 5-HT1B antagonists |
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525087 Use of known agonists of the central cannabinoid receptor CB1 |
| 02/25/2003 | US6525083 Antidiabetic agents, antilipemic agents, anticholesterol agents |
| 02/25/2003 | US6525079 Antiparasitic compounds such as 4-(2,2-dibromocyclopropyl)-1-(2,6-dichloro-4-trifluoromethylphenyl)-1,2,3 -triazole |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6525020 For drug delivery |
| 02/25/2003 | US6524382 Pigmented vitreous material |
| 02/20/2003 | WO2003014732A1 Apparatuses and methods for creating and testing pre-formulations and systems for same |
| 02/20/2003 | WO2003014255A1 Fluorescent diketopyrrolopyrrole analogues |
| 02/20/2003 | WO2003014083A1 Spiro compounds |
| 02/20/2003 | WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors |
| 02/20/2003 | WO2003014081A1 Process for producing optically active azetidine-2-carboxylic acid |
| 02/20/2003 | WO2003014069A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2003013512A2 Crystalline forms of fluvastatin sodium |
| 02/20/2003 | WO2003013510A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 02/20/2003 | WO2002074742A3 Cdk-inhibitory indirubin derivatives having an increased solubility |
| 02/20/2003 | WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof |
| 02/20/2003 | WO2002048097B1 Compounds, compositions and methods for treatment of parasitic infections |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | US20030036559 Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3-[2- (2-methoxyphenoxy) -ethylamino] -2-propanole process for its preparation and pharmaceutical compositions containing it |
| 02/20/2003 | US20030036538 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest. |
| 02/20/2003 | US20030035836 Oral controlled release pharmaceutical composition for once-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
| 02/20/2003 | CA2456599A1 Spiro compounds |
| 02/20/2003 | CA2455754A1 Amine derivatives |
| 02/20/2003 | CA2454072A1 Crystalline forms of fluvastatin sodium |
| 02/20/2003 | CA2453245A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 02/19/2003 | EP1284260A1 Tyrosine phosphatase inhibitors |
| 02/19/2003 | EP1283836A2 Neuroprotective and anti-proliferative compounds |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1192191B1 Method for producing condensation compounds |
| 02/19/2003 | EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1397550A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1397549A Novel derivative of 2-azadicyclo-(2,2,1) heptane, its prepn. and use |
| 02/19/2003 | CN1101815C 3-aminochromanylsulfonyl (thio) ureas, processes for their prepn. their use, and pharmaceutical prepn. comprising them |
| 02/18/2003 | US6521788 Process for the preparation of 1-aminomethyl-1-cyclohexaneacetic acid |
| 02/18/2003 | US6521667 Calcilytic compounds |
| 02/18/2003 | US6521658 Cell proliferation inhibitors |
| 02/18/2003 | US6521657 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
| 02/18/2003 | US6521638 2,3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
| 02/18/2003 | US6521603 Fungicides for the control of take-all disease of plants |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/13/2003 | WO2003011872A1 Platelet adp receptor inhibitors |
| 02/13/2003 | WO2003011858A1 Substituted isoindoles and e use thereof |
| 02/13/2003 | WO2003011834A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 02/13/2003 | WO2003011833A1 Indazole or indole derivatives, their use in human medicine and more particularly in cancerology |
| 02/13/2003 | WO2003011827A1 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives |
| 02/13/2003 | WO2003011815A1 Bicyclic heteroaromatic alanines |
| 02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
| 02/13/2003 | WO2003011808A1 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 02/13/2003 | WO2003011396A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 02/13/2003 | WO2003011290A1 Methods for inhibiting or reversing tau filament formation polymerization |
| 02/13/2003 | WO2003011284A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 02/13/2003 | WO2002076988A3 Tert. alkylphenoxy substituted polycyclic compounds |
| 02/13/2003 | WO2002059082A8 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 02/13/2003 | WO2002055492A3 An improved process for preparing pure ondansetron hydrochloride dihydrate |
| 02/13/2003 | WO2002033110A3 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 02/13/2003 | US20030032666 Crystalline forms |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | US20030032626 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 02/13/2003 | US20030032581 Pharmaceuticals for treating obesity |